The largest database of trusted experimental protocols

C6295

Manufactured by Merck Group
Sourced in Germany

The C6295 is a laboratory equipment product manufactured by Merck Group. It is a general-purpose device designed for use in research and scientific settings. The core function of the C6295 is to perform specific tasks required for laboratory operations. No further details about the intended use or capabilities of the C6295 are provided.

Automatically generated - may contain errors

3 protocols using c6295

1

Immortalized Cell Culture Cryopreservation and Passage

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immortalized cells were cultured according to standard practices. Briefly, cells were cryopreserved in low glucose DMEM (11885084, Thermo Fisher, Darmstadt, Germany) supplemented with 20% FBS (S0615-500ML, Sigma-Aldrich, Taufkirchen, Germany) and 10% DMSO (C6295, Sigma-Aldrich) in liquid N2. To bring them in culture, cryovials were thawed and resuspended in warmed complete medium made of DMEM supplemented with 10% FBS and 1% Anti/Anti (15240062, Thermo Fisher). The cell suspension was centrifuged at 0.5 rcf for 5′ to remove the DMSO, the cell pellet was resuspended in complete medium and transferred to a sterile T-75 flask. Cells were maintained in an incubator at 37 °C, 5% CO2, 85–95% humidity and passaged once 90% confluent. For passaging, the medium was aspirated, the cells washed once with DPBS-CaCl2 and then detached from the flask using 0.05% Trypsin-EDTA (5′ incubation at 37 °C, 5% CO2). Cells were counted using 0.4% Trypan Blue Stain (T10282, Thermo Fisher) and the Countess3 FL Automated Cell Counter (Thermo Fisher) before seeding in a new recipient.
+ Open protocol
+ Expand
2

Investigating miR-22 and CDDP in MG63 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MG63 cells with or without miR-22 transfection were divided into two groups: A control group and an inhibitor group. DMSO at a concentration of 10 µM (C6295; Sigma-Aldrich; Merck KGaA) was added to the cells of the control group. Wortmannin at a concentration of 10 µM (S2758; Selleck Chemicals) was added to the cells of the inhibitor group. Each group had four treatment subgroups, comprising treatments of MG63, MG63+miR-22, MG63+CDDP and MG63+CDDP+miR-22. Subsequently, RT-quantitative (q)PCR and western blot analysis were performed.
+ Open protocol
+ Expand
3

Cryopreserved iPSC-Derived Sphere Growth

Check if the same lab product or an alternative is used in the 5 most similar protocols
EZ spheres were prepared from iPSCs and then dissociated and sorted as described above. Cells in the CD271+ fraction and CD15 fraction were transferred into expansion medium to reform spheres. A parallelly prepared group of cells that did not go through MACS was used as control, referred to as “unsorted cells.” After 6 weekly passages by mechanical chopping, spheres were transferred into the cell freezing medium (C6295, Sigma-Aldrich) and stored in liquid nitrogen for 2 years. Cryopreserved spheres were then thawed and transferred into the expansion medium. After spheres were passaged once a week and maintained for 6 weeks, 8 spheres per group were transferred into the wells of a low-attachment 96-well plate on day 0. Each well contained one sphere with a similar size (~20 μm diameter) in the expansion medium. On day 0, day 3, day 6, and day 9, diameters of the spheres were measured with the eyepiece reticle of the Nikon Eclipse TS 100 inverted microscope and used to calculate the sphere volume. Growth rates were calculated by normalizing each sphere's changes in volume relative to the initial volume on day 0. To verify the reliability of our findings, we repeated 3 independent experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!